{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:45:28Z","timestamp":1761489928719,"version":"3.40.5"},"reference-count":30,"publisher":"VM Media Group sp. z o.o","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologia i Neurochirurgia Polska"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.pjnns.2016.03.008","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T13:12:09Z","timestamp":1459602729000},"page":"288-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The molecular pattern of histopathological progression to anaplastic meningioma \u2013 A case report"],"prefix":"10.5603","volume":"50","author":[{"given":"Waldemar","family":"Och","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Kulbacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u0142a\u017cej","family":"Szostak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Sikorska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Zakrzewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1904-6773","authenticated-orcid":false,"given":"Tomasz","family":"Szmuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142 P.","family":"Liberski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Budzisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3595","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.pjnns.2016.03.008_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","article-title":"Pathological classification and molecular genetics of meningiomas","volume":"99","author":"Mawrin","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.pap.0000175117.47918.f7","article-title":"Molecular diagnostics in central nervous system tumors","volume":"12","author":"Fuller","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"Suppl. 5","key":"10.1016\/j.pjnns.2016.03.008_bib0175","first-page":"110","article-title":"Correlation of expression of progesterone receptors with histopathological type and grade of malignancy of cerebral neoplasms","volume":"35","author":"Och","year":"2001","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0180","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/07357900601062339","article-title":"Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma","volume":"24","author":"Grunberg","year":"2006","journal-title":"Cancer Invest"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10014-009-0251-2","article-title":"Recurrence and regrowth of benign meningiomas","volume":"26","author":"Nakasu","year":"2009","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0190","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2011.2.FOCUS1116","article-title":"The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments","volume":"30","author":"Choy","year":"2011","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0195","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"20","author":"Simpson","year":"1957","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0200","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","article-title":"The WHO classification of tumors of the nervous system","volume":"61","author":"Kleihues","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0205","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/ijc.23297","article-title":"Narrowing of the regions of allelic losses of chromosome 1p36 in meningioma tissues by an improved SSCP analysis","volume":"122","author":"Guan","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0210","first-page":"411","article-title":"Primary resected meningiomas: relapses and proliferation markers","volume":"18","author":"Kalala","year":"2004","journal-title":"In Vivo"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0215","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1227\/01.NEU.0000170980.47582.A5","article-title":"Diagnosis and treatment of atypical and anaplastic meningiomas: a review","volume":"57","author":"Modha","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0220","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1215\/S1152851704000158","article-title":"Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas","volume":"6","author":"Pfisterer","year":"2004","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0225","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1349-7006.2009.01308.x","article-title":"Genetic alterations and signaling pathways in the evolution of gliomas","volume":"100","author":"Ohgaki","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0230","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1476-4598-6-64","article-title":"Molecular signatures define two main classes of meningiomas","volume":"6","author":"Carvalho","year":"2007","journal-title":"Mol Cancer"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0235","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","article-title":"Histological classification and molecular genetics of meningiomas","volume":"5","author":"Riemenschneider","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1750-3639.2002.tb00433.x","article-title":"A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas","volume":"12","author":"Perry","year":"2002","journal-title":"Brain Pathol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0245","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2006.11.052","article-title":"CHD5 is a tumor suppressor at human 1p36","volume":"128","author":"Bagchi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0250","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","article-title":"Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0255","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","article-title":"Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma","volume":"65","author":"Lusis","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0260","first-page":"4443","article-title":"Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival","volume":"9","author":"Mihaila","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0265","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10024001-0086-2","article-title":"Deletion of the NF2 region in both meningioma and juxtaposed meningioangiomatosis: case report supporting a neoplastic relationship","volume":"4","author":"Sinkre","year":"2001","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cancergencyto.2008.01.020","article-title":"BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region","volume":"183","author":"Wozniak","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0275","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1750-3639.2009.00340.x","article-title":"Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas","volume":"20","author":"Barski","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0280","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s10014-012-0117-x","article-title":"Reduced expression of ELAVL4 in male meningioma patients","volume":"30","author":"Stawski","year":"2013","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0285","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-0891","article-title":"Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status","volume":"16","author":"Goutagny","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0290","doi-asserted-by":"crossref","first-page":"e94987","DOI":"10.1371\/journal.pone.0094987","article-title":"Molecular biological determinations of meningioma progression and recurrence","volume":"9","author":"Linsler","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0295","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/jns.2004.101.2.0210","article-title":"Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings","volume":"101","author":"Al-Mefty","year":"2004","journal-title":"J Neurosurg"},{"key":"10.1016\/j.pjnns.2016.03.008_bib0300","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1227\/01.NEU.0000290895.92695.22","article-title":"De novo versus transformed atypical and anaplastic meningiomas: comparisons of clinical course, cytogenetics, cytokinetics, and outcome","volume":"61","author":"Krayenbuhl","year":"2007","journal-title":"Neurosurgery"}],"container-title":["Neurologia i Neurochirurgia Polska"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384316300160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384316300160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T12:35:27Z","timestamp":1718454927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028384316300160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0028384316300160"],"URL":"https:\/\/doi.org\/10.1016\/j.pjnns.2016.03.008","relation":{},"ISSN":["0028-3843"],"issn-type":[{"type":"print","value":"0028-3843"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The molecular pattern of histopathological progression to anaplastic meningioma \u2013 A case report","name":"articletitle","label":"Article Title"},{"value":"Neurologia i Neurochirurgia Polska","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pjnns.2016.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}